Open AccessPercutaneous ethanol injection as a promising and minimally invasive treatment for axillary osmidrosis: Double-blinded randomized controlled trial
Author(s) -
Ali Asilian,
Masoom Shahbazi,
Bahareh AbtahiNaeini,
Nazila Poostiyan,
Mohammad Ali Nilforoushzadeh
Publication year - 2018
Publication title -
indian journal of dermatology, venereology, and leprology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.514
H-Index - 45
eISSN - 0973-3922
pISSN - 0378-6323
DOI - 10.4103/ijdvl.ijdvl_704_16
Subject(s) - medicine , surgery , randomized controlled trial , percutaneous , placebo , complication , randomization , apocrine , syringe , saline , anesthesia , alternative medicine , pathology , anatomy , psychiatry
Axillary osmidrosis is a common problem with a strong negative impact on the professional and social quality of life. Several options are available for its treatment. But there are no treatment guidelines. The objective of this study was to evaluate efficacy and safety of percutaneous ethanol injection for treatment of axillary osmidrosis.